IP Library Granted Patent US 10,610,643
Granted Patent B2
US 10,610,643 · App. 15/404,442 · Granted Apr 7, 2020

Occlusion resolution in medication delivery devices, systems, and methods

Inventors: Bryan Mazlish (Palo Alto, CA); Lane Desborough (Thousand Oaks, CA); Ravi Shankar Rontala Raghunathan (Union City, CA)
Assignee: Bigfoot Biomedical, Inc.
A61M5/1723A61M5/00A61M5/16854A61M5/172G06F19/3468A61M2005/16863A61M2202/07A61M2205/18A61M2205/332A61M2205/3331A61M2205/3334A61M2205/3569A61M2205/3584A61M2205/502A61M2205/581A61M2205/582A61M2205/583A61M2205/587A61M2230/201
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,610,643
App. No.
15/404,442
Granted
Apr 7, 2020
Kind
B2
Abstract

Methods, devices, and systems of delivering infusion fluid (e.g., medication such as insulin) can detect, at multiple times during a dispensation period of time, a pressure level of the infusion fluid in an infusion fluid pathway, either directly or indirectly. Based on the detected pressure levels, one or more actual dispensation times that are after an intended dispensation time can be determined. In some cases, methods, devices, and systems provided herein can use variable occlusion alarm thresholds, which can depend on variables such as an age of an infusion set and/or a current analyte level. In some cases, methods, devices, and systems provided herein can automate medication delivery and use the actual dispensation times in a control algorithm determining medication deliveries.

Claims (17)

1. A method of operating a portable infusion pump system, the method comprising:

initiating a dispensation of an infusion fluid by a pump of the portable infusion pump system;

identifying an intended dispensation time at which the dispensation of the infusion fluid is initiated;

detecting, at multiple times during a dispensation period of time, pressure measurements of the infusion fluid in an infusion fluid pathway of the pump;

identifying pressure data predetermined for the infusion pump system, the pressure data indicative of a pressure change of the infusion fluid pathway in an occluded condition, the pressure data including one or more threshold pressure values;

comparing each of pressure measurements detected at the multiple times during the dispensation period to the one or more threshold pressure values; and

determining, based on one or more of the detected pressure measurements exceeding the one or more of the threshold pressure values of the pressure data, that the dispensation occurred at an actual dispensation time that is delayed from the intended dispensation time due at least in part to the occluded condition; and

determining an amount of the infusion fluid delivered from the actual dispensation time.

2. The method of claim 1 , wherein the infusion fluid is insulin.

3. The method of claim 2 , wherein control circuitry of the infusion pump system calculates an estimate of insulin-on-board based on the amount of the infusion fluid delivered from the actual dispensation time.

4. The method of claim 2 , further comprising receiving, from a blood glucose detection device, at least one blood glucose level, wherein an amount of insulin in the dispensation is determined based at least in part upon the at least one blood glucose level and an estimate of insulin-on-board.

5. The method of claim 4 , wherein the one or more pressure threshold values include a variable alarm threshold, the method further comprising outputting an occlusion alarm if one or more of the detected pressure measurements exceeds the variable alarm threshold, the variable alarm threshold being dependent upon at least one detected blood glucose value.

6. The method of claim 5 , wherein the variable alarm threshold is further dependent on a timing of one or more recent dispensations, amount of one or more recent dispensations, type of one or more recent dispensations, or a combination thereof.

7. The method of claim 2 , further comprising predicting a future blood glucose level based on the actual dispensation time and the amount of the infusion fluid delivered from the actual dispensation time.

8. The method of claim 2 , further comprising determining an amount of insulin that is stuck in transit in the infusion fluid pathway of the pump due to the occluded condition based on the pressure data, wherein the actual dispensation time is determined based on a time that the detected pressure decreases to a predetermined level, wherein an amount of insulin stuck in transit is excluded from an insulin-on-board calculation performed by control circuitry of the portable infusion pump system.

9. The method of claim 1 , wherein, in response to determining that the dispensation occurred at an actual dispensation time that is after the intended dispensation time, delaying or reducing a subsequent dispensation of the infusion fluid.

10. The method of claim 1 , wherein the pressure level is determined or estimated using a pressure sensor or a force sensor.

Assignments (16)
SECURITY INTEREST Recorded Jan 10, 2025
From: MADRYN HEALTH PARTNERS, LP
To: MADRYN FUND ADMINISTRATION, LLC
Reel/Frame 069870/0519 →
SECURITY INTEREST Recorded Jan 10, 2025
From: BIGFOOT BIOMEDICAL, INC.
To: MADRYN HEALTH PARTNERS, LP
Reel/Frame 069870/0456 →
SECURITY INTEREST Recorded Sep 30, 2024
From: BIGFOOT BIOMEDICAL, INC.
To: MADRYN HEALTH PARTNERS, LP
Reel/Frame 069073/0912 →
SECURITY INTEREST Recorded Sep 30, 2024
From: MADRYN HEALTH PARTNERS, LP
To: MADRYN FUND ADMINISTRATION, LLC
Reel/Frame 069074/0001 →
SECURITY INTEREST Recorded Sep 24, 2024
From: BIGFOOT BIOMEDICAL, INC.
To: MADRYN HEALTH PARTNERS, LP
Reel/Frame 069030/0296 →
SECURITY INTEREST Recorded Sep 24, 2024
From: MADRYN HEALTH PARTNERS, LP
To: MADRYN FUND ADMINISTRATION, LLC
Reel/Frame 069030/0104 →
SECURITY INTEREST Recorded Sep 23, 2024
From: BIGFOOT BIOMEDICAL, INC.
To: MADRYN HEALTH PARTNERS, LP
Reel/Frame 069019/0142 →
SECURITY INTEREST Recorded Sep 23, 2024
From: MADRYN HEALTH PARTNERS, LP
To: MADRYN FUND ADMINISTRATION, LLC
Reel/Frame 069019/0188 →
SECURITY INTEREST Recorded Sep 12, 2024
From: MADRYN HEALTH PARTNERS, LP
To: MADRYN FUND ADMINISTRATION, LLC
Reel/Frame 068948/0324 →
SECURITY INTEREST Recorded Sep 12, 2024
From: BIGFOOT BIOMEDICAL, INC.
To: MADRYN HEALTH PARTNERS, LP
Reel/Frame 068948/0172 →
SECURITY AGREEMENT SUPPLEMENT Recorded Sep 7, 2023
From: INSULET CORPORATION
To: MORGAN STANLEY SENIOR FUNDING, INC., AS COLLATERAL AGENT
Reel/Frame 064840/0181 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 1, 2023
From: BIGFOOT BIOMEDICAL, INC.
To: INSULET CORPORATION
Reel/Frame 062900/0001 →
RELEASE OF SECURITY INTEREST Recorded Feb 17, 2023
From: MADRYN FUND ADMINISTRATION, LLC
To: BIGFOOT BIOMEDICAL, INC.
Reel/Frame 062793/0316 →
SECURITY INTEREST Recorded Feb 10, 2023
From: MADRYN HEALTH PARTNERS, LP
To: MADRYN FUND ADMINISTRATION, LLC
Reel/Frame 062702/0145 →
SECURITY INTEREST Recorded Mar 12, 2021
From: BIGFOOT BIOMEDICAL, INC.
To: MADRYN HEALTH PARTNERS, LP
Reel/Frame 055583/0044 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 5, 2017
From: MAZLISH, BRYAN; DESBOROUGH, LANE; RAGHUNATHAN, RAVI SHANKAR RONTALA
To: BIGFOOT BIOMEDICAL, INC.
Reel/Frame 041861/0738 →
Continuity (2)
Provisional Application 62278974 · Jan 14, 2016
Related Publication 20170203036A1 · Jul 20, 2017
Cited By (2)
US 12,343,501 US 12,678,556